v3.25.2
Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited) - USD ($)
Common Stock
Previously Reported
Common Stock
Additional Paid-in- Capital
Previously Reported
Additional Paid-in- Capital
Accumulated Deficit
Previously Reported
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Previously Reported
Accumulated Other Comprehensive Income (Loss)
Preferred Stock
Previously Reported
Series A-2
Preferred Stock
Previously Reported
Series A-1
Preferred Stock
Previously Reported
Series A
Preferred Stock
Series A-2
Preferred Stock
Series A-1
Preferred Stock
Series A
Private Veea Common Stock
Previously Reported
Private Veea Common Stock
Previously Reported
Total
Balance at Dec. 31, 2022 $ 1,535 $ 123,779,186 $ 123,778,433 $ (154,849,725) $ (154,849,725) $ 772,034 $ 772,034 $ 351 $ 359 $ 72 $ (30,297,723) $ (30,297,723)
Balance (in Shares) at Dec. 31, 2022 15,345,255             35,094,893 35,920,813 7,203,514    
Retroactive application of Business Combination (Note 1)   $ 1,535   (753)           $ (351) $ (359)   $ (72)  
Retroactive application of Business Combination (Note 1) (in Shares)   15,345,255                   (35,094,893) (35,920,813)   (7,203,514)    
Common stock issued upon exercise of stock options   $ 1   3               4
Common stock issued upon exercise of stock options (in Shares)   7,847                        
Stock based compensation due to common stock purchase options     484,584               484,584
Series A-2 Preferred Stock Issuances, net of transaction costs   $ 242   17,256,283               17,256,525
Series A-2 Preferred Stock Issuances, net of transaction costs (in Shares)   2,422,870                        
Conversion of convertible notes and accrued interest   $ 107   10,949,090               10,949,197
Conversion of convertible notes and accrued interest (in Shares)   1,074,022                        
Issuance of warrants in connection with term note   $ 12   2,010,286               2,010,298
Issuance of warrants in connection with term note (in Shares)   119,732                        
Conversion of promissory notes to Series A-2 Preferred Stock   $ 41   3,076,233               3,076,274
Conversion of promissory notes to Series A-2 Preferred Stock (in Shares)   410,170                        
Conversion of vendor payable to Series A-2 Preferred Stock   $ 26   1,920,098               1,920,124
Conversion of vendor payable to Series A-2 Preferred Stock (in Shares)   256,017                          
Foreign currency translation gain (loss)         (1,433,388)               (1,433,388)
Change in ownership percentage of non-controlling interest       205,564                 205,564
Net income (loss)       (15,638,589)                 (15,638,589)
Balance at Dec. 31, 2023   $ 1,964   159,475,010   (170,282,750)   (661,354)           (11,467,130)
Balance (in Shares) at Dec. 31, 2023   19,635,912                        
Series A-2 Preferred Stock Issuances, net of transaction costs   $ 168   11,955,239                           11,955,407
Series A-2 Preferred Stock Issuances, net of transaction costs (in Shares)   1,675,502                                
Conversion of vendor payable to Series A-2 Preferred Stock   $ 1   78,422                           78,423
Conversion of vendor payable to Series A-2 Preferred Stock (in Shares)   10,456                                
Stock based compensation for stock options       62,670                           62,670
Foreign currency translation gain (loss)               365,381                   365,381
Net income (loss)           (6,018,994)                       (6,018,994)
Balance at Mar. 31, 2024   $ 2,133   171,571,341   (176,301,744)   (295,973)                   (5,024,243)
Balance (in Shares) at Mar. 31, 2024   21,321,870                                
Balance at Dec. 31, 2023   $ 1,964   159,475,010   (170,282,750)   (661,354)           (11,467,130)
Balance (in Shares) at Dec. 31, 2023   19,635,912                        
Common stock issued upon exercise of stock options   $ 4   25,480               $ 25,484
Common stock issued upon exercise of stock options (in Shares)   41,556                        
Common stock issued upon draw on the equity line of credit (in Shares)                                   2,000,000
Settlement of convertible note agreement for shares issued     (16,302,389)               $ (16,302,389)
Series A-2 Preferred Stock Issuances, net of transaction costs   $ 169   12,009,963               12,010,132
Series A-2 Preferred Stock Issuances, net of transaction costs (in Shares)   1,682,799                        
Common stock issued upon exercise of stock options, pre Business Combination   $ 2   53,998               54,000
Common stock issued upon exercise of stock options, pre Business Combination (in Shares)   19,618                        
Exercise of Common Stock Warrants - related party   $ 76   (76)              
Exercise of Common Stock Warrants - related party (in Shares)   756,912                        
Issuance of Common Stock in exchange for services in connection with A-2 Preferred Stock Issuances, recasted   $ 61   (62)               (1)
Issuance of Common Stock in exchange for services in connection with A-2 Preferred Stock Issuances, recasted (in Shares)   615,385                        
Issuance of Common Stock upon conversion of debt at Business Combination (Note 1)   $ 315   15,739,531               15,739,846
Issuance of Common Stock upon conversion of debt at Business Combination (Note 1) (in Shares)   3,147,970                        
Issuance of Common Stock upon conversion of Sponsor and related party notes and warrants at Business Combination (Note 1)   $ 82   2,205,415               2,205,497
Issuance of Common Stock upon conversion of Sponsor and related party notes and warrants at Business Combination (Note 1) (in Shares)   817,453                        
Issuance of Common Stock to Plum Sponsors and Investors at Business Combination (Note 1)   $ 610   241,638               242,248
Issuance of Common Stock to Plum Sponsors and Investors at Business Combination (Note 1) (in Shares)   6,102,562                        
Issuance of Common Stock to Plum Shareholders at Business Combination (Note 1)   $ 60   (6,901,658)               (6,901,598)
Issuance of Common Stock to Plum Shareholders at Business Combination (Note 1) (in Shares)   603,077                        
Issuance of Common Stock related to new financing (Note 1)   $ 200   23,999,800               24,000,000
Issuance of Common Stock related to new financing (Note 1) (in Shares)   2,000,000                        
Common Stock issued for services   $ 24   3,214,597               3,214,621
Common Stock issued for services (in Shares)   241,667                        
Common stock issued upon exercise of stock options, post Business Combination   $ 2   (2)              
Common stock issued upon exercise of stock options, post Business Combination (in Shares)   25,000                        
Warrant exercise   $ 8   (8)              
Warrant exercise (in Shares)   79,653                        
Common Stock issued as stock based compensation for restricted stock units   $ 41   1,249,959   1,250,000            
Common Stock issued as stock based compensation for restricted stock units (in Shares)   405,580                        
Conversion of vendor payable to Series A-2 Preferred Stock   $ 3   207,405               207,408
Conversion of vendor payable to Series A-2 Preferred Stock (in Shares)   27,654                        
Stock based compensation for stock options     5,449,081               5,449,081
Foreign currency translation gain (loss)         795,745           795,745
Net income (loss)       (47,547,768)             (47,547,768)
Balance at Dec. 31, 2024   $ 3,621   200,667,682   (217,830,518)   134,391           (17,024,824)
Balance (in Shares) at Dec. 31, 2024   36,202,798                        
Stock based compensation       50,000                           50,000
Common stock issued upon exercise of stock options   $ 2   8.67                           11
Common stock issued upon exercise of stock options (in Shares)   24,420                                
Common stock issued upon draw on the equity line of credit   $ 24   604,402                           604,426
Common stock issued upon draw on the equity line of credit (in Shares)   240,500                                
Common stock issued as compensation for equity line of credit commitment fee   $ 3   24,997                           25,000
Common stock issued as compensation for equity line of credit commitment fee (in Shares)   27,498                                
Settlement of convertible note agreement for shares issued   $ 5   349,995                           350,000
Settlement of convertible note agreement for shares issued (in Shares)   46,666                                
Cumulative translation adjustment               20,411                   20,411
Net income (loss)           4,299,052                       4,299,052
Balance at Mar. 31, 2025   $ 3,655   $ 201,697,086   $ (213,531,466)   $ 154,802                   $ (11,675,924)
Balance (in Shares) at Mar. 31, 2025   36,541,882